Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001765581-25-000064
Filing Date
2025-08-08
Accepted
2025-08-08 14:33:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2893
  Complete submission text file 0001765581-25-000064.txt   4593
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN Ireland D04 E5W7
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN Ireland D04 E5W7 353-1-634-7800
Jazz Pharmaceuticals plc (Subject) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-33500 | Film No.: 251197862
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TELADOC HEALTH, INC. 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577
Business Address
Smith Mark Douglas (Reporting) CIK: 0001756253 (see all company filings)

Type: 144